Citation Impact
Citing Papers
Clinical Practice Guidelines for the Management Candidiasis: 2009 Update by the Infectious Diseases Society of America
2009 Standout
Clinical Practice Guidelines for the Management of Cryptococcal Disease: 2010 Update by the Infectious Diseases Society of America
2010 Standout
In Vitro Activities of Posaconazole, Fluconazole, Itraconazole, Voriconazole, and Amphotericin B against a Large Collection of Clinically Important Molds and Yeasts
2006
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
2009 Standout
Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem
2007 Standout
Epidemiology of Invasive Mycoses in North America
2010
Invasive Aspergillosis in Hematological Patients
2016
Treatment of Refractory Coccidioidomycosis With Voriconazole or Posaconazole
2011
Impact of Treatment Strategy on Outcomes in Patients with Candidemia and Other Forms of Invasive Candidiasis: A Patient-Level Quantitative Review of Randomized Trials
2012 Standout
In VitroAntifungal Activity of Isavuconazole against 345 Mucorales Isolates Collected at Study Centers in Eight Countries
2009
Isavuconazole: A New Broad-Spectrum Triazole Antifungal Agent
2015
Guidelines for Preventing Infectious Complications among Hematopoietic Cell Transplantation Recipients: A Global Perspective
2009 Standout
Natural products: A continuing source of novel drug leads
2013 Standout
Posaconazole or Fluconazole for Prophylaxis in Severe Graft-versus-Host Disease
2007 Standout
Natural products: An evolving role in future drug discovery
2011 Standout
Advances in synthetic approach to and antifungal activity of triazoles
2011
Safety of triazole antifungal drugs in patients with cancer
2009
State‐of‐the‐Art Treatment of Coccidioidomycosis
2007
Fungal infections of the skin and nail: new treatment options
2014
Posaconazole Therapy for Chronic Refractory Coccidioidomycosis
2007
Posaconazole for Chronic Refractory Coccidioidal Meningitis
2011
Nosocomial fungal infections: epidemiology, diagnosis, and treatment
2007
Fungal infections in solid organ transplantation
2007
Therapy for fungal diseases: opportunities and priorities
2010
In vitro interaction of posaconazole with calcineurin inhibitors and sirolimus against zygomycetes
2010
Candida albicanspathogenicity mechanisms
2013 Standout
Coccidioidomycosis in liver transplantation
2005
Safety, Tolerance, and Efficacy of Posaconazole Therapy in Patients with Nonmeningeal Disseminated or Chronic Pulmonary Coccidioidomycosis
2007
Methods for in vitro evaluating antimicrobial activity: A review
2015 Standout
Safety of Long-Term Oral Posaconazole Use in the Treatment of Refractory Invasive Fungal Infections
2006
Invasive fungal infections in solid organ transplant recipients
2014
A sensitive liquid chromatography and mass spectrometry method for the determination of posaconazole in human plasma
2006
Mould-active azoles: pharmacokinetics, drug interactions in neutropenic patients
2007
Current Options in Antifungal Pharmacotherapy
2008
Vertebral Coccidioidomycosis: Presentation and Multidisciplinary Management
2012
Natural products to drugs: natural product-derived compounds in clinical trials
2008 Standout
Posaconazole: a broad-spectrum triazole antifungal
2005
State‐of‐the‐Art Treatment of Coccidioidomycosis Skeletal Infections
2007
Emerging echinocandins for treatment of invasive fungal infections
2006
Posaconazole: A Broad-Spectrum Triazole Antifungal Agent
2007
Pharmacokinetics of Oral Posaconazole in Allogeneic Hematopoietic Stem Cell Transplant Recipients with Graft‐versus‐Host Disease
2007
Posaconazole salvage treatment in paediatric patients: a multicentre survey
2010
Changing epidemiology of systemic fungal infections
2008
The Top 10 fungal pathogens in molecular plant pathology
2012 Standout
Antifungal agents – clinical pharmacokinetics and drug interactions
2008
Pharmacokinetic/Pharmacodynamic Profile of Posaconazole
2010
Prevention and Early Treatment of Invasive Fungal Infection in Patients with Cancer and Neutropenia and in Stem Cell Transplant Recipients in the Era of Newer Broad-Spectrum Antifungal Agents and Diagnostic Adjuncts
2007
Voriconazole in the treatment of fungal eye infections: a review of current literature
2008
Mycoses in Pediatric Patients
2006
Coccidioidal Meningitis
2010
Co-infections in people with COVID-19: a systematic review and meta-analysis
2020 Standout
Mold Infections of the Central Nervous System
2014
Antifungal therapy in invasive fungal infections
2010
A paradigm for the evaluation and management of spinal coccidioidomycosis
2015
Posaconazole Is Effective as Salvage Therapy in Zygomycosis: A Retrospective Summary of 91 Cases
2006
Addressing current medical needs in invasive fungal infection prevention and treatment with new antifungal agents, strategies and formulations
2011
Combination Therapy for Mucormycosis: Why, What, and How?
2012
Reversed Halo Sign in Invasive Pulmonary Fungal Infections
2008
Recent advances in antifungal chemotherapy
2007
Posaconazole vs. Fluconazole or Itraconazole Prophylaxis in Patients with Neutropenia
2007 Standout
Tie2-dependent VHL knockdown promotes airway microvascular regeneration and attenuates invasive growth of Aspergillus fumigatus
2013 StandoutNobel
An Official American Thoracic Society Statement: Treatment of Fungal Infections in Adult Pulmonary and Critical Care Patients
2010
Histoplasmosis: a Clinical and Laboratory Update
2007
Practice Guidelines for the Diagnosis and Management of Skin and Soft Tissue Infections: 2014 Update by the Infectious Diseases Society of America
2014 Standout
Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)
2013 Standout
Guidelines for the Prevention and Treatment of Opportunistic Infections among HIV-exposed and HIV-infected children: recommendations from CDC, the National Institutes of Health, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics.
2009
Echinocandin and Triazole Antifungal Susceptibility Profiles for Clinical Opportunistic Yeast and Mold Isolates Collected from 2010 to 2011: Application of New CLSI Clinical Breakpoints and Epidemiological Cutoff Values for Characterization of Geographic and Temporal Trends of Antifungal Resistance
2013
2016 Infectious Diseases Society of America (IDSA) Clinical Practice Guideline for the Treatment of Coccidioidomycosis
2016 Standout
Invasive Fungal Pathogens: Current Epidemiological Trends
2006
Azole-Based Energetic Salts
2011 Standout
Prevention and Treatment of Cancer-Related Infections
2012
Fusarium Infections in Immunocompromised Patients
2007
Global and Multi-National Prevalence of Fungal Diseases—Estimate Precision
2017 Standout
Nitrile-Containing Pharmaceuticals: Efficacious Roles of the Nitrile Pharmacophore
2010 Standout
Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America
2011 Standout
Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas
2016 Standout
Pharmacokinetics and Safety of Oral Posaconazole in Neutropenic Stem Cell Transplant Recipients
2006
2015 Infectious Diseases Society of America (IDSA) Clinical Practice Guidelines for the Diagnosis and Treatment of Native Vertebral Osteomyelitis in Adultsa
2015 Standout
Cross-Reactivity of Fusarium spp. in the Aspergillus Galactomannan Enzyme-Linked Immunosorbent Assay
2011
Posaconazole: A Next-Generation Triazole Antifungal
2007
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
2016 Standout
A new solid oral tablet formulation of posaconazole: a randomized clinical trial to investigate rising single- and multiple-dose pharmacokinetics and safety in healthy volunteers
2012
Antifungal Therapeutic Drug Monitoring: Established and Emerging Indications
2008
Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America
2015 Standout
Antifungal susceptibility testing inAspergillusspp. according to EUCAST methodology
2006
Posaconazole Exposure-Response Relationship: Evaluating the Utility of Therapeutic Drug Monitoring
2012
Single-Dose Phase I Study To Evaluate the Pharmacokinetics of Posaconazole in New Tablet and Capsule Formulations Relative to Oral Suspension
2012
Posaconazole Tablet Pharmacokinetics: Lack of Effect of Concomitant Medications Altering Gastric pH and Gastric Motility in Healthy Subjects
2014
Treatment of Aspergillosis: Clinical Practice Guidelines of the Infectious Diseases Society of America
2008 Standout
Therapeutic Drug Monitoring of Posaconazole: a Monocentric Study with 54 Adults
2009
Posaconazole
2007
Hidden Killers: Human Fungal Infections
2012 Standout
Recent Advances in Our Understanding of the Environmental, Epidemiological, Immunological, and Clinical Dimensions of Coccidioidomycosis
2013
Clinical Practice Guidelines for the Management of Patients with Histoplasmosis: 2007 Update by the Infectious Diseases Society of America
2007 Standout
Wild-Type MIC Distributions and Epidemiological Cutoff Values for Posaconazole and Voriconazole and Candida spp. as Determined by 24-Hour CLSI Broth Microdilution
2010
Works of Gavin Corcoran being referenced
Posaconazole as Salvage Therapy for Zygomycosis
2005
Refractory Coccidioidomycosis Treated with Posaconazole
2005
Posaconazole as Salvage Treatment for Invasive Fusariosis in Patients with Underlying Hematologic Malignancy and Other Conditions
2006
Salvage treatment of histoplasmosis with posaconazole
2006
Markedly Elevated Serum Lactate Dehydrogenase Levels Are a Clue to the Diagnosis of Disseminated Histoplasmosis in Patients with AIDS
1997
Pharmacokinetics, Safety, and Efficacy of Posaconazole in Patients with Persistent Febrile Neutropenia or Refractory Invasive Fungal Infection
2006